液体活检与眼部肿瘤:综述。

IF 0.9 Q3 OPHTHALMOLOGY
Journal of Current Ophthalmology Pub Date : 2025-09-18 eCollection Date: 2024-10-01 DOI:10.4103/joco.joco_88_24
Celine Chaaya, Andrea Sarkis, Georges El Haddad, Ernest Diab, Alexandre Schakal
{"title":"液体活检与眼部肿瘤:综述。","authors":"Celine Chaaya, Andrea Sarkis, Georges El Haddad, Ernest Diab, Alexandre Schakal","doi":"10.4103/joco.joco_88_24","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To explore the various applications of liquid biopsy (LB) in ophthalmology and provide a comprehensive discussion on its utility in the field.</p><p><strong>Methods: </strong>A thorough exploration of the literature was conducted, and a total of 47 articles were included.</p><p><strong>Results: </strong>In RB, where conventional tumor biopsies carry risks of spreading the tumor beyond the eye, LB, particularly from the aqueous humor, emerges as a promising alternative. It provides a secure means of detecting cfDNA. In addition, LB is effective in uveal melanoma, particularly through digital droplet PCR, in mutation detection and predicting disease progression. Moreover, vitreous LB proves highly effective in diagnosing vitreoretinal lymphoma, exhibiting greater sensitivity than traditional cytopathological methods. This noninvasive approach not only enhances diagnostic accuracy but also holds potential for guiding biologically targeted therapies, showcasing the ongoing advancements in LB technology poised to redefine and revolutionize the field.</p><p><strong>Conclusion: </strong>These findings offer valuable insights for personalized treatment strategies in ocular malignancies.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":"36 4","pages":"348-354"},"PeriodicalIF":0.9000,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12487790/pdf/","citationCount":"0","resultStr":"{\"title\":\"Liquid Biopsy and Ocular Tumors: A Review.\",\"authors\":\"Celine Chaaya, Andrea Sarkis, Georges El Haddad, Ernest Diab, Alexandre Schakal\",\"doi\":\"10.4103/joco.joco_88_24\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>To explore the various applications of liquid biopsy (LB) in ophthalmology and provide a comprehensive discussion on its utility in the field.</p><p><strong>Methods: </strong>A thorough exploration of the literature was conducted, and a total of 47 articles were included.</p><p><strong>Results: </strong>In RB, where conventional tumor biopsies carry risks of spreading the tumor beyond the eye, LB, particularly from the aqueous humor, emerges as a promising alternative. It provides a secure means of detecting cfDNA. In addition, LB is effective in uveal melanoma, particularly through digital droplet PCR, in mutation detection and predicting disease progression. Moreover, vitreous LB proves highly effective in diagnosing vitreoretinal lymphoma, exhibiting greater sensitivity than traditional cytopathological methods. This noninvasive approach not only enhances diagnostic accuracy but also holds potential for guiding biologically targeted therapies, showcasing the ongoing advancements in LB technology poised to redefine and revolutionize the field.</p><p><strong>Conclusion: </strong>These findings offer valuable insights for personalized treatment strategies in ocular malignancies.</p>\",\"PeriodicalId\":15423,\"journal\":{\"name\":\"Journal of Current Ophthalmology\",\"volume\":\"36 4\",\"pages\":\"348-354\"},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2025-09-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12487790/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Current Ophthalmology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/joco.joco_88_24\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/10/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Current Ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/joco.joco_88_24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:探讨液体活检(LB)在眼科中的各种应用,并对其在该领域的应用进行全面的探讨。方法:深入查阅文献,共纳入47篇。结果:在RB中,传统的肿瘤活检有肿瘤扩散到眼睛以外的风险,LB,特别是房水LB,是一种有希望的替代方法。它提供了一种安全的检测cfDNA的方法。此外,LB在葡萄膜黑色素瘤中,特别是通过数字液滴PCR,在突变检测和预测疾病进展方面是有效的。此外,玻璃体LB对诊断玻璃体视网膜淋巴瘤非常有效,表现出比传统细胞病理学方法更高的敏感性。这种非侵入性方法不仅提高了诊断准确性,而且具有指导生物靶向治疗的潜力,展示了LB技术的持续进步,有望重新定义和彻底改变该领域。结论:这些发现为眼科恶性肿瘤的个性化治疗策略提供了有价值的见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Liquid Biopsy and Ocular Tumors: A Review.

Purpose: To explore the various applications of liquid biopsy (LB) in ophthalmology and provide a comprehensive discussion on its utility in the field.

Methods: A thorough exploration of the literature was conducted, and a total of 47 articles were included.

Results: In RB, where conventional tumor biopsies carry risks of spreading the tumor beyond the eye, LB, particularly from the aqueous humor, emerges as a promising alternative. It provides a secure means of detecting cfDNA. In addition, LB is effective in uveal melanoma, particularly through digital droplet PCR, in mutation detection and predicting disease progression. Moreover, vitreous LB proves highly effective in diagnosing vitreoretinal lymphoma, exhibiting greater sensitivity than traditional cytopathological methods. This noninvasive approach not only enhances diagnostic accuracy but also holds potential for guiding biologically targeted therapies, showcasing the ongoing advancements in LB technology poised to redefine and revolutionize the field.

Conclusion: These findings offer valuable insights for personalized treatment strategies in ocular malignancies.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.50
自引率
6.70%
发文量
45
审稿时长
8 weeks
期刊介绍: Peer Review under the responsibility of Iranian Society of Ophthalmology Journal of Current Ophthalmology, the official publication of the Iranian Society of Ophthalmology, is a peer-reviewed, open-access, scientific journal that welcomes high quality original articles related to vision science and all fields of ophthalmology. Journal of Current Ophthalmology is the continuum of Iranian Journal of Ophthalmology published since 1969.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信